Nishiura T, Suzuki K, Kawaguchi T, Nakao H, Kawamura N, Taniguchi M, Kanayama Y, Yonezawa T, Iizuka S, Taniguchi N
Department of Biochemistry, Osaka University Medical School, Japan.
Cancer Lett. 1992 Mar 15;62(3):211-5. doi: 10.1016/0304-3835(92)90098-g.
We measured the serum levels of manganese-superoxide dismutase (Mn-SOD) in acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL). Serum Mn-SOD level for normal subjects was 94.1 +/- 23.5 ng/ml (mean +/- S.D.), the levels for AML and ALL patients were 159.6 +/- 77.1 ng/ml and 154.4 +/- 77.0 ng/ml, respectively. The serum Mn-SOD levels were unrelated to individual intracellular Mn-SOD levels, but correlated well with serum lactate dehydrogenase values. Regression of the leukemia was accompanied by decrease in the serum level of Mn-SOD. Serum Mn-SOD may thus serve as a measure of the activity of the disease.
我们检测了急性髓系白血病(AML)和急性淋巴细胞白血病(ALL)患者血清中锰超氧化物歧化酶(Mn-SOD)的水平。正常受试者血清Mn-SOD水平为94.1±23.5 ng/ml(均值±标准差),AML患者和ALL患者的血清Mn-SOD水平分别为159.6±77.1 ng/ml和154.4±77.0 ng/ml。血清Mn-SOD水平与个体细胞内Mn-SOD水平无关,但与血清乳酸脱氢酶值密切相关。白血病病情缓解时,血清Mn-SOD水平会下降。因此,血清Mn-SOD可作为疾病活动度的一项指标。